Heart News and Research

RSS

Checklists can help surgical teams perform better during emergencies

When doctors, nurses and other hospital operating room staff follow a written safety checklist to respond when a patient experiences cardiac arrest, severe allergic reaction, bleeding followed by an irregular heart beat or other crisis during surgery, they are nearly 75 percent less likely to miss a critical clinical step, according to a new study funded by the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality.

19 Jan 2013

St. Jude Medical’s AMPLATZER Amulet device receives European CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced European CE Mark approval of its AMPLATZER Amulet Left Atrial Appendage Occluder.

19 Jan 2013

CRF to sponsor 8th International Conference on Cell Therapy for Cardiovascular Disease

The final agenda for the Eighth International Conference on Cell Therapy for Cardiovascular Disease, sponsored by the Cardiovascular Research Foundation, is now available online.

19 Jan 2013

Mental health improvements are a key part of Obama's plan to reduce gun violence

In addition to calling for changes in how the country handles gun sales, the proposal would increase mental health services, finish rules on mental health parity and restore federal gun research.

18 Jan 2013

Medications often prescribed for PAH could affect heart health of treated patients

A research team with the Faculty of Medicine & Dentistry at the University of Alberta reported findings that significantly improve understanding of how widely used drugs in Pulmonary Arterial Hypertension (PAH) affect the heart health of treated patients.

18 Jan 2013

Researchers: Operating room checklists, good work environments for nurses help reduce errors, readmissions

Having step-by-step checklists on hand may help doctors and nurses manage emergencies in the operating room, a new study suggests. In situations when a person's heart stops beating on the operating table or a patient begins bleeding uncontrollably, those lists can save time and brainpower, researchers said.

18 Jan 2013

Boehringer Ingelheim initiates enrollment in Phase III IFN-free HCV trial

Today, Boehringer Ingelheim announced that the first patients have been enrolled in the company's pivotal Phase III interferon (IFN)-free hepatitis C (HCV) clinical trial programme, HCVerso.

18 Jan 2013

Lack or excess of CaM kinase II affects heart muscle cell stiffness

A certain enzyme, the CaM kinase II, keeps the cardiac muscle flexible. By transferring phosphate groups to the giant protein titin, it relaxes the muscle cells. This is reported by researchers led by Prof. Dr. Wolfgang Linke of the Institute of Physiology at the Ruhr Universität in the journal Circulation Research. In failing hearts, which don't pump enough blood around the body, the scientists found an overly active CaM kinase II.

18 Jan 2013

Intermountain Risk Score tool can predict mortality among trauma patients

A simple, inexpensive blood test performed on trauma patients upon admission can help doctors easily identify patients at greatest risk of death, according to a new study by researchers at Intermountain Medical Center in Salt Lake City.

18 Jan 2013

nContact receives FDA clearance for EPi-Sense cardiac ablation device

nContact, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's modifications to its VisiTrax cardiac ablation device, EPi-Sense, now with embedded sensing capability.

18 Jan 2013

Octapharma receives FDA approval for Octaplas to treat blood clotting disorders

The U.S. Food and Drug Administration today approved Octaplas, a pooled plasma (human) blood product for the replacement of clotting proteins (coagulation factors) in certain medical conditions where patients have insufficient levels.

18 Jan 2013

Atrial fibrillation increases risk of kidney failure in people with CKD

Many people who suffer from chronic kidney disease progressively lose their kidney function over time and eventually develop a condition called end-stage renal disease - the complete failure of the kidneys - placing them in need of lifelong dialysis or a kidney transplant.

18 Jan 2013

Potential stem cell therapy for Duchenne’s

Researchers have found that injecting aorta-derived stem cells into the hearts of dystrophin-deficient mice prevents the onset of dilated cardiomyopathy, raising hopes of a potential new treatment approach to prevent or reverse the condition in human Duchenne muscular dystrophy.

17 Jan 2013

Women who have migraine with aura more likely to develop major cardiovascular events

Women who have migraines with aura, which are often visual disturbances such as flashing lights, may be more likely to have problems with their heart and blood vessels, and those on newer contraceptives may be at higher risk for blood clots, according to two studies released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

17 Jan 2013

Polypill could reduce CVD and stroke in Latin Americans by up to 21% at lower cost

A single combination pill could reduce cardiovascular disease and stroke in Latin Americans by up to 21 percent at a cost of about $35 per quality adjusted life year gained, according to a study led by a University of Wisconsin School of Medicine and Public Health research team.

17 Jan 2013

American Association of Heart Failure Nurses, Milner-Fenwick announce partnership

Milner-Fenwick, a multi-media publisher for the healthcare community, and the American Association of Heart Failure Nurses (AAHFN) announced a partnership which includes the AAHFN's endorsement of Milner-Fenwick's Heart Failure Patient Education Video Series.

17 Jan 2013

State roundup: Maine hospitals fighting for timely Medicaid payments

New York police plan to distribute "bait bottles" of fake pain-killers equipped with invisible GPS devices in a drive to combat the scourge of pharmacy robberies by addicts and sellers looking for oxycodone tablets, which can fetch more than $80 per pill on the street.

17 Jan 2013

Boston Scientific initiates Blazer Open-Irrigated Catheter clinical trial in atrial fibrillation

The first patient has been treated in the Boston Scientific Corporation ZERO AF clinical trial to evaluate the safety and effectiveness of the Blazer Open-Irrigated Temperature Ablation Catheter in patients with symptomatic, drug refractory paroxysmal atrial fibrillation.

17 Jan 2013

People most often visit doctors because of skin issues, joint disorders and back pain

A new Mayo Clinic Proceedings study shows that people most often visit their health care providers because of skin issues, joint disorders and back pain. Findings may help researchers focus efforts to determine better ways to prevent and treat these conditions in large groups of people.

17 Jan 2013

FDA approves St. Jude Medical’s Merlin.net Patient Care Network

St. Jude Medical, Inc., a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of the next-generation Merlin.net Patient Care Network (PCN), a secure, Internet-based remote care system for patients with implanted medical devices.

17 Jan 2013

Heart News and Research

Checklists can help surgical teams perform better during emergencies

St. Jude Medical’s AMPLATZER Amulet device receives European CE Mark approval

CRF to sponsor 8th International Conference on Cell Therapy for Cardiovascular Disease

Mental health improvements are a key part of Obama's plan to reduce gun violence

Medications often prescribed for PAH could affect heart health of treated patients

Researchers: Operating room checklists, good work environments for nurses help reduce errors, readmissions

Boehringer Ingelheim initiates enrollment in Phase III IFN-free HCV trial

Lack or excess of CaM kinase II affects heart muscle cell stiffness

Intermountain Risk Score tool can predict mortality among trauma patients

nContact receives FDA clearance for EPi-Sense cardiac ablation device

Octapharma receives FDA approval for Octaplas to treat blood clotting disorders

Atrial fibrillation increases risk of kidney failure in people with CKD

Potential stem cell therapy for Duchenne’s

Women who have migraine with aura more likely to develop major cardiovascular events

Polypill could reduce CVD and stroke in Latin Americans by up to 21% at lower cost

American Association of Heart Failure Nurses, Milner-Fenwick announce partnership

State roundup: Maine hospitals fighting for timely Medicaid payments

Boston Scientific initiates Blazer Open-Irrigated Catheter clinical trial in atrial fibrillation

People most often visit doctors because of skin issues, joint disorders and back pain

FDA approves St. Jude Medical’s Merlin.net Patient Care Network

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News